ELUT · Healthcare · $35M
After-hours $0.790.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 326 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 핵심 변화는 회사가 여러 사업을 정리하고 NXT-41x 하나에 자금과 인력을 집중할 기반을 마련했다는 점이에요.”
In the company's words · 2026 2분기 earnings call